Musculoskeletal Consequences of COVID-19

Area of Science:

• Virology
• Musculoskeletal Health
• Computational Biology

Background:

• Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is a global pandemic.
• SARS-CoV-2 shares similarities with SARS-CoV-1, impacting multiple organ systems, including the musculoskeletal system.
• Previous SARS outbreaks documented muscle pain, dysfunction, osteoporosis, and osteonecrosis.

Purpose of the Study:

• To summarize known musculoskeletal pathologies in SARS and COVID-19 patients.
• To predict SARS-CoV-2's musculoskeletal cellular targets and long-term consequences.
• To integrate clinical data with computational and biochemical signaling studies.

Main Methods:

• Literature review of musculoskeletal conditions associated with SARS and COVID-19.
• Computational modeling to identify cellular targets.
• Biochemical signaling pathway analysis.

Main Results:

• SARS-CoV-2 infection can lead to significant musculoskeletal dysfunction.
• Similarities between SARS-CoV-1 and SARS-CoV-2 suggest comparable long-term musculoskeletal sequelae.
• Identified potential cellular mechanisms and targets for musculoskeletal complications.

Conclusions:

• COVID-19 may result in persistent musculoskeletal problems.
• Further long-term studies are needed to fully understand COVID-19's impact on muscles and bones.
• Computational and biochemical approaches can aid in predicting and managing these complications.